4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-076916
Chief Operating Officer sold 3,366 shares at $56.09 ($188,799)
- Chief Operating Officer acquired 7,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bruno Julianne Chief Operating Officer | 2024-06-20 | Option exercise | +7,000 | 10,111 | D | ||
| Bruno Julianne Chief Operating Officer | 2024-06-21 | Sale | −3,366 | $56.09 | $188,799 | 6,745 | D |
| Derivatives | |||||||
| Bruno Julianne Chief Operating Officer | 2024-06-20 | Option exercise · Restricted Stock Units | −7,000 | 0 | D | ||
| Open-market sales · 3,366 sh · avg $56.09 · $188,799 | |||||||
Loading xslF345X05/ownership.xml…